Article
Triple therapy offers local control for high-risk PCa
Author(s):
New York-A combination of hormonal therapy, brachytherapy, andexternal beam radiation has demonstrated excellent local control in high-riskprostate cancer patients.
Related Videos
Stacy Loeb, MD, MSc, PhD (Hon), discusses the nuances of prostate cancer screening
Maria Uloko, MD, on the need for better education on female sexual dysfunction
Dean Elterman, MD, on the shift toward personalized care in BPH
Jad Chahoud, MD, on the phase 1b STELLAR-002 trial in ccRCC
Selecting Between Receptor Pathway Inhibitors for mHSPC
The Use of Ultra-Low PSA in Specific Patient Profiles
Fred Saad, MD, FRCS, discusses clinical impact of darolutamide approval in mCSPC
The MOA of TLX250
The importance of studying efficacy and safety of treatment in Black patients with mHSPC
The ZIRCON Trial
Related Content
